• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大医学生群体中的大麻教育需求评估。

Cannabis education needs assessment among Canadian physicians-in-training.

机构信息

Department of Psychology, The University of British Columbia, Kelowna, BC, Canada.

Faculty of Medicine, The University of British Columbia, Kelowna, BC, Canada.

出版信息

Complement Ther Med. 2020 Mar;49:102328. doi: 10.1016/j.ctim.2020.102328. Epub 2020 Jan 31.

DOI:10.1016/j.ctim.2020.102328
PMID:32147035
Abstract

BACKGROUND

Since 1999, the Canadian courts have recognized the rights of patients to access cannabis for therapeutic purposes (CTP). Due to the increasing interest in the use of CTP, competency with the topic among health care providers is essential. As concerns mount around the role of industry involvement in cannabis education, it has become increasingly important for medical schools to provide physicians-in-training balanced evidence regarding the harms and benefits of CTP. In the present study, we surveyed Canadian physicians-in-training regarding their knowledge, experience, attitudes, and barriers surrounding CTP.

METHODS

Survey questions were adapted from extant physician and nurse practitioner education needs assessments. We invited representatives from all 17 Canadian universities with a Faculty of Medicine to electronically distribute the survey to physicians-in-training.

RESULTS

The survey was accessed by 93 physicians-in-training of whom 76 provided responses (46 % female; M = 28, SD = 3.03). Physicians-in-training reported receiving significantly less instruction on CTP than they desired. Responses demonstrated differences between current and desired knowledge across all domains queried. More education was the factor identified as most likely to increase comfort authorizing and discussing CTP with patients.

CONCLUSIONS

Findings from this study demonstrate an expressed desire for more education surrounding CTP among a self-selected sample of Canadian physicians-in-training. There was a substantial divergence between current and desired levels of knowledge, and the largest gaps related to creating effective treatment plans and understanding the risks and benefits of CTP. Improving the educational opportunities of students will improve standard-of-care for patients.

摘要

背景

自 1999 年以来,加拿大法院承认患者获取大麻用于治疗目的(CTP)的权利。由于人们对 CTP 使用的兴趣日益浓厚,医疗保健提供者掌握该主题的知识至关重要。随着人们对行业参与大麻教育的关注不断增加,医学院为接受培训的医生提供有关 CTP 的危害和益处的平衡证据变得越来越重要。在本研究中,我们调查了加拿大接受培训的医生对 CTP 的知识、经验、态度和障碍。

方法

调查问题改编自现有的医生和护士从业者教育需求评估。我们邀请了所有 17 所拥有医学院的加拿大大学的代表,通过电子方式向接受培训的医生分发调查。

结果

有 93 名接受培训的医生访问了该调查,其中 76 名提供了回复(46%为女性;M=28,SD=3.03)。接受培训的医生报告说,他们接受的 CTP 指导明显少于他们所期望的。答复表明,在所查询的所有领域中,当前知识与期望知识之间存在差异。更多的教育被认为是最有可能增加授权和与患者讨论 CTP 的舒适度的因素。

结论

本研究的结果表明,在加拿大接受培训的医生中,自我选择的样本对 CTP 周围的更多教育表示出渴望。当前和期望的知识水平之间存在很大差距,最大的差距与制定有效的治疗计划和理解 CTP 的风险和益处有关。改善学生的教育机会将改善患者的护理标准。

相似文献

1
Cannabis education needs assessment among Canadian physicians-in-training.加拿大医学生群体中的大麻教育需求评估。
Complement Ther Med. 2020 Mar;49:102328. doi: 10.1016/j.ctim.2020.102328. Epub 2020 Jan 31.
2
Cannabis in medicine: a national educational needs assessment among Canadian physicians.医学中的大麻:加拿大医生的全国性教育需求评估
BMC Med Educ. 2015 Mar 19;15:52. doi: 10.1186/s12909-015-0335-0.
3
A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes.一项关于加拿大执业护士对大麻用于治疗目的的全国需求评估。
Cannabis Cannabinoid Res. 2018 Mar 1;3(1):66-73. doi: 10.1089/can.2018.0002. eCollection 2018.
4
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.医用大麻:患者特征、获取途径和使用原因。
Int J Drug Policy. 2013 Nov;24(6):511-6. doi: 10.1016/j.drugpo.2013.08.010. Epub 2013 Sep 9.
5
Barriers to access for Canadians who use cannabis for therapeutic purposes.为治疗目的使用大麻的加拿大人面临的准入障碍。
Int J Drug Policy. 2014 Jul;25(4):691-9. doi: 10.1016/j.drugpo.2014.02.009. Epub 2014 Feb 28.
6
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada. dispensaries 是否不可或缺?加拿大从医用大麻药房获取大麻的患者体验。
Int J Drug Policy. 2017 Sep;47:1-8. doi: 10.1016/j.drugpo.2017.05.046. Epub 2017 Jun 28.
7
Clinician Attitudes, Training, and Beliefs About Cannabis: An Interprofessional Assessment.临床医生对大麻的态度、培训和信念:一种跨专业评估。
Cannabis Cannabinoid Res. 2023 Jun;8(3):547-556. doi: 10.1089/can.2021.0022. Epub 2021 Dec 31.
8
Development of a Canadian deceased donation education program for health professionals: a needs assessment survey.开发加拿大针对卫生专业人员的器官捐献教育计划:需求评估调查。
Can J Anaesth. 2017 Oct;64(10):1037-1047. doi: 10.1007/s12630-017-0882-4. Epub 2017 May 3.
9
Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians.大麻医师的教育、知识和实践特点:对大麻临床医生学会的调查。
Cannabis Cannabinoid Res. 2021 Feb 12;6(1):58-65. doi: 10.1089/can.2019.0025. eCollection 2021.
10
Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices.医疗保健从业者对影响大麻处方实践障碍的看法。
BMC Complement Med Ther. 2022 Sep 8;22(1):237. doi: 10.1186/s12906-022-03716-9.

引用本文的文献

1
Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer.肿瘤学研究员向成年癌症患者推荐医用大麻的模式及影响因素。
J Cannabis Res. 2025 Jul 14;7(1):45. doi: 10.1186/s42238-025-00293-9.
2
Patient-provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study.关于大麻用于治疗目的的医患互动因提供者类型而异:一项试点研究。
Am J Addict. 2025 May;34(3):277-288. doi: 10.1111/ajad.13656. Epub 2024 Oct 24.
3
Cannabis-related information sources among US residents: A probability-weighted nationally representative survey.
美国居民中与大麻相关的信息来源:一项概率加权的全国代表性调查。
J Cannabis Res. 2024 Oct 1;6(1):38. doi: 10.1186/s42238-024-00249-5.
4
Cannabis Use, Perspectives, and Experiences Among Patients Receiving Hemodialysis: A Descriptive Patient Survey.接受血液透析患者的大麻使用情况、观点及体验:一项描述性患者调查
Can J Kidney Health Dis. 2024 Sep 21;11:20543581241274002. doi: 10.1177/20543581241274002. eCollection 2024.
5
"Like the Wild West": Health care provider perspectives on impacts of recreational cannabis legalization on patients and providers at a tertiary psychiatric hospital in Ontario, Canada.“像狂野西部一样”:加拿大安大略省一家三级精神病医院的卫生保健提供者对娱乐性大麻合法化对患者和提供者影响的看法。
J Subst Use Addict Treat. 2024 Dec;167:209487. doi: 10.1016/j.josat.2024.209487. Epub 2024 Aug 15.
6
Patient-provider communication about the use of medical cannabis for cancer symptoms: a cross-sectional study.患者与医务人员就癌症症状使用医用大麻进行沟通:一项横断面研究。
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):298-304. doi: 10.1093/jncimonographs/lgad026.
7
The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products.医疗保健专业人员对大麻类产品的态度、知识和信心。
J Cannabis Res. 2024 Jul 24;6(1):32. doi: 10.1186/s42238-024-00242-y.
8
The Use of Compounds Derived from in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.在癫痫、疼痛病症以及神经精神和神经退行性疾病的治疗中使用来源于 的化合物。
Int J Mol Sci. 2024 May 25;25(11):5749. doi: 10.3390/ijms25115749.
9
Planting the seeds for success: A qualitative study exploring primary healthcare providers' perceptions about medical cannabis.为成功播下种子:一项定性研究探索初级保健提供者对医用大麻的看法。
PLoS One. 2024 Mar 7;19(3):e0295858. doi: 10.1371/journal.pone.0295858. eCollection 2024.
10
Individuals' Values and Preferences Regarding Medical Cannabis for Chronic Pain: A Descriptive Qualitative Study.个体对医用大麻治疗慢性疼痛的价值观和偏好:一项描述性定性研究。
J Pain Res. 2024 Jan 3;17:21-34. doi: 10.2147/JPR.S432823. eCollection 2024.